Active Ingredient(s):Sirolimus Albumin-Bound Nanoparticles FDA Approved: * November 22, 2021 Pharm Company: *AADI BIOSCIENCE INC Category:Cancer
Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumor (PEComa). It has immunosuppressant functions in humans and is especially useful in preventing the rejection of kidney transplants....
* May have multiple approval dates, manufacturers, or labelers.
Fyarro 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Suspension